D.E. Shaw & Co’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.5K | Sell |
22,199
-483,270
| -96% | -$295K | ﹤0.01% | 3005 |
|
|
2025
Q1 | $382K | Sell |
505,469
-341,595
| -40% | -$258K | ﹤0.01% | 2561 |
|
|
2024
Q4 | $815K | Sell |
847,064
-70,006
| -8% | -$67.3K | ﹤0.01% | 2197 |
|
|
2024
Q3 | $1.32M | Buy |
917,070
+81,032
| +10% | +$117K | ﹤0.01% | 2039 |
|
|
2024
Q2 | $1.01M | Buy |
836,038
+510,089
| +156% | +$617K | ﹤0.01% | 2183 |
|
|
2024
Q1 | $766K | Sell |
325,949
-20,670
| -6% | -$48.6K | ﹤0.01% | 2234 |
|
|
2023
Q4 | $655K | Buy |
346,619
+101,746
| +42% | +$192K | ﹤0.01% | 2262 |
|
|
2023
Q3 | $335K | Buy |
244,873
+213,419
| +679% | +$292K | ﹤0.01% | 2436 |
|
|
2023
Q2 | $76.4K | Sell |
31,454
-13,151
| -29% | -$32K | ﹤0.01% | 2715 |
|
|
2023
Q1 | $257K | Buy |
+44,605
| New | +$257K | ﹤0.01% | 2726 |
|
|
2022
Q4 | – | Sell |
-112,355
| Closed | -$1.6M | – | 3581 |
|
|
2022
Q3 | $1.6M | Sell |
112,355
-219,457
| -66% | -$3.12M | ﹤0.01% | 2260 |
|
|
2022
Q2 | $4.84M | Buy |
331,812
+110,685
| +50% | +$1.62M | 0.01% | 1583 |
|
|
2022
Q1 | $4.42M | Buy |
221,127
+8,670
| +4% | +$173K | ﹤0.01% | 1780 |
|
|
2021
Q4 | $3.72M | Buy |
212,457
+168,586
| +384% | +$2.95M | ﹤0.01% | 1942 |
|
|
2021
Q3 | $344K | Sell |
43,871
-28,163
| -39% | -$221K | ﹤0.01% | 3003 |
|
|
2021
Q2 | $741K | Buy |
72,034
+39,548
| +122% | +$407K | ﹤0.01% | 2683 |
|
|
2021
Q1 | $425K | Buy |
32,486
+7,969
| +33% | +$104K | ﹤0.01% | 2554 |
|
|
2020
Q4 | $344K | Buy |
24,517
+12,223
| +99% | +$172K | ﹤0.01% | 2416 |
|
|
2020
Q3 | $146K | Sell |
12,294
-13,424
| -52% | -$159K | ﹤0.01% | 2442 |
|
|
2020
Q2 | $387K | Buy |
+25,718
| New | +$387K | ﹤0.01% | 2254 |
|
|
2020
Q1 | – | Sell |
-23,447
| Closed | -$245K | – | 2633 |
|
|
2019
Q4 | $245K | Buy |
+23,447
| New | +$245K | ﹤0.01% | 2438 |
|